Home › Funds › ACORN CAPITAL ADVISORS, LLC › OKUR
ACORN CAPITAL ADVISORS, LLC position in OKUR
ONKURE THERAPEUTICS INC · Health Care
ACORN CAPITAL ADVISORS, LLC reported holding 2,839,674 shares of OKUR (ONKURE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$7.8M, representing 2.13% of its reported portfolio and ranking #10 among its reported holdings. ACORN CAPITAL ADVISORS, LLC has disclosed OKUR holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ACORN CAPITAL ADVISORS, LLC's OKUR position evolved
ACORN CAPITAL ADVISORS, LLC first disclosed a stake in OKUR in Q4 2024 at 1,439,674 shares (US$10.2M). The position peaked in Q2 2026 at 2,839,674 shares, worth US$12.9M. Across 8 filings, ACORN CAPITAL ADVISORS, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 2,839,674 shares valued at US$7.8M. Notable position changes include a 97% increase in Q2 2025 (shares rose 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 1.44M | $10.25M | New |
| Q1 2025 | 1.44M | $5.12M | Hold |
| Q2 2025 | 2.84M | $6.79M | Add |
| Q3 2025 | 2.84M | $7.81M | Hold |
| Q4 2025 | 2.84M | $8.24M | Hold |
| Q1 2026 | 2.84M | $11.76M | Hold |
| Q2 2026 | 2.84M | $12.95M | Hold |
| Q3 2026 | 2.84M | $7.75M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OKUR and 13F data
OKUR (ONKURE THERAPEUTICS INC) is a Health Care company. 64 other funds we track also report a position in OKUR — the largest reported positions include BVF INC/IL (US$14.8M), StepStone Group LP (US$12.1M), Vivo Capital, LLC (US$5.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OKUR
- BVF INC/IL 3.24M sh · $14.76M · Q2 2026
- StepStone Group LP 2.66M sh · $12.13M · Q2 2026
- Vivo Capital, LLC 1.93M sh · $5.25M · Q3 2026
- Prosight Management, LP 1.33M sh · $3.61M · Q3 2026
- Sio Capital Management, LLC 1.08M sh · $2.95M · Q3 2026
- NEA Management Company, LLC 478.55K sh · $2.18M · Q2 2026
- Trails Edge Capital Partners, LP 619.56K sh · $1.69M · Q3 2026
- Carlyle Group Inc. 269.89K sh · $735.46K · Q3 2026
- Stonepine Capital Management, LLC 162.82K sh · $443.68K · Q3 2026
- Aisling Capital Management LP 88.61K sh · $241.45K · Q3 2026
- Rosalind Advisors, Inc. 67.51K sh · $183.95K · Q3 2026
- Aldebaran Capital, LLC 39.36K sh · $107.25K · Q3 2026
More on ACORN CAPITAL ADVISORS, LLC
FAQ
How long has ACORN CAPITAL ADVISORS, LLC held OKUR?
ACORN CAPITAL ADVISORS, LLC has disclosed OKUR holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is ACORN CAPITAL ADVISORS, LLC's current position in OKUR?
As of Q3 2026, ACORN CAPITAL ADVISORS, LLC holds 2.84M shares of OKUR (ONKURE THERAPEUTICS INC), valued at $7.75M, representing 2.13% of its reported portfolio and ranking #10.
Has ACORN CAPITAL ADVISORS, LLC been buying or selling OKUR?
In the latest 13F filing (Q3 2026), ACORN CAPITAL ADVISORS, LLC held unchanged its position in OKUR. The position peaked in Q2 2026 at 2.84M shares.
Which other funds hold OKUR?
Other major institutional holders of OKUR include BVF INC/IL, StepStone Group LP, Vivo Capital, LLC, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.